{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:15:30Z","timestamp":1792822530766,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>It is unclear whether IV milrinone relaxes spasmed cerebral arteries and therefore reduces cerebral blood mean velocity (V<jats:sub>mean<\/jats:sub>). In patients treated for cerebral vasospasm, we aimed to assess and delineate the respective impacts of induced hypertension and its combination with IV milrinone on cerebral hemodynamics as assessed with transcranial Doppler.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Observational proof-of-concept prospective study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>ICU in a French tertiary care center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with aneurysmal subarachnoid hemorrhage who received induced hypertension (mean arterial blood pressure [MBP] of 100\u2013120\u2009mm Hg) and IV milrinone (0.5 \u00b5g\/kg\/min) for moderate-to-severe cerebral vasospasm. We excluded patients who underwent invasive angioplasty or milrinone discontinuation within 12 hours after the diagnosis of vasospasm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>V<jats:sub>mean<\/jats:sub> was measured at vasospasm diagnosis (T<jats:sub>DIAGNOSIS<\/jats:sub>), after the induction of hypertension (T<jats:sub>HTN<\/jats:sub>), and 1 (T<jats:sub>HTN+MILRINONE_H1<\/jats:sub>) and 12 hours after the adjunction of IV milrinone (T<jats:sub>HTN+MILRINONE_H12<\/jats:sub>). Thirteen patients were included. Median V<jats:sub>mean<\/jats:sub> was significantly lower (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01) at T<jats:sub>HTN+MILRINONE_H1<\/jats:sub> (99 [interquartile range (IQR) 89; 134] cm.s<jats:sup>\u22121<\/jats:sup>) and T<jats:sub>HTN+MILRINONE_H12<\/jats:sub> (85 [IQR 73\u2013127] cm\/s) than at T<jats:sub>DIAGNOSIS<\/jats:sub> (136 [IQR 115\u2013164] cm\/s) and T<jats:sub>HTN<\/jats:sub> (148 [IQR 115\u2013183] cm\/s), whereas T<jats:sub>DIAGNOSIS<\/jats:sub> and T<jats:sub>HTN<\/jats:sub> did not significantly differ. In all patients but one, V<jats:sub>mean<\/jats:sub> at T<jats:sub>HTN+MILRINONE_H1<\/jats:sub> was lower than its value at T<jats:sub>DIAGNOSIS<\/jats:sub> (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0005). V<jats:sub>mean<\/jats:sub>-to-MBP and V<jats:sub>mean<\/jats:sub>-to-cardiac output (CO) ratios (an assessment of V<jats:sub>mean<\/jats:sub> regardless of the level of MBP [<jats:italic toggle=\"yes\">n<\/jats:italic> = 13] or CO [<jats:italic toggle=\"yes\">n<\/jats:italic> = 7], respectively) were, respectively, similar at T<jats:sub>DIAGNOSIS<\/jats:sub> and T<jats:sub>HTN<\/jats:sub> but were significantly lower after the adjunction of milrinone (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>The induction of arterial hypertension was not associated with a significant decrease in V<jats:sub>mean<\/jats:sub>, whereas the adjunction of IV milrinone was, regardless of the level of MBP or CO. This suggests that IV milrinone may succeed in relaxing spasmed arteries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000973","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T22:58:24Z","timestamp":1694732304000},"page":"e0973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cerebral Vasospasm After Subarachnoid Hemorrhage: Respective Short-Term Effects of Induced Arterial Hypertension and its Combination With IV Milrinone: A Proof-of-Concept Study Using Transcranial Doppler Ultrasound"],"prefix":"10.1097","volume":"5","author":[{"given":"Karim","family":"Lakhal","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Critical Care, La\u00ebnnec Hospital, University Hospital of Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion H.","family":"Fresco","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, La\u00ebnnec Hospital, University Hospital of Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hivert","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, La\u00ebnnec Hospital, University Hospital of Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Rozec","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, La\u00ebnnec Hospital, University Hospital of Nantes, France."},{"name":"Institut du Thorax, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universit\u00e9 de Nantes, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cadiet","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, La\u00ebnnec Hospital, University Hospital of Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(22)00938-2","article-title":"Spontaneous subarachnoid haemorrhage.","volume":"400","author":"Claassen","year":"2022","journal-title":"Lancet Lond Engl"},{"key":"R2-20240807","article-title":"A survey on monitoring and management of cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage: The Mantra study.","author":"Picetti","year":"2023","journal-title":"J Neurosurg Anesthesiol"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ANA.0000000000000755","article-title":"Treatment of subarachnoid hemorrhage-associated delayed cerebral ischemia with milrinone: A review and proposal.","volume":"33","author":"Bernier","year":"2021","journal-title":"J Neurosurg Anesthesiol"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12028-021-01331-z","article-title":"Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: The MILRISPASM controlled before-after study.","volume":"35","author":"Lakhal","year":"2021","journal-title":"Neurocrit Care"},{"key":"R5-20240807","first-page":"168","article-title":"Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: A survey of European practice.","volume":"32","author":"Velly","year":"2015","journal-title":"Eur J Anaesthesiol"},{"key":"R6-20240807","article-title":"Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage.","author":"Treggiari","year":"2023","journal-title":"Neurocrit Care"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/CCM.0000000000003459","article-title":"Transcranial Doppler in the diagnosis of cerebral vasospasm: A call for a dynamic approach.","volume":"47","author":"Lakhal","year":"2019","journal-title":"Crit Care Med"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3171\/2020.1.JNS193107","article-title":"Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia.","volume":"134","author":"Abulhasan","year":"2020","journal-title":"J Neurosurg"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12028-021-01378-y","article-title":"Induced hypertension or intravenous milrinone for cerebral vasospasm: Why choose?","volume":"35","author":"Lakhal","year":"2021","journal-title":"Neurocrit Care"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12028-021-01288-z","article-title":"Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.","volume":"36","author":"Rouanet","year":"2022","journal-title":"Neurocrit Care"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.wneu.2022.06.150","article-title":"Role of nimodipine and milrinone in delayed cerebral ischemia.","volume":"166","author":"Kotwal","year":"2022","journal-title":"World Neurosurg"},{"key":"R12-20240807","doi-asserted-by":"crossref","DOI":"10.1007\/s12028-023-01789-z","article-title":"Treating vasospasm with IV milrinone: Relax (the vessel) or don\u2019t do it!","author":"Robert-Edan","year":"2023","journal-title":"Neurocrit Care"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T01:07:58Z","timestamp":1722992878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000973","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}